At a glance
ClinicalIndex Comparison RecordN/ACompleted· 39 enrolled
Drug / intervention
BRAVO capsule +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
DUAL BRAVO PH MONITORING: A Feasibility Trial
In Brief
A clinical study evaluating BRAVO capsule, Fluoroscopy, and 1 other intervention for Gastroesophageal Reflux Disease. Completed, enrolled 39 participants across 1 site.
Detailed Summary
Assessing the feasibility and patient tolerance to placement of Bravo PH capsule in proximal esophagus. There will be no difference in patient-perception of a proximally-placed Bravo esophageal pH monitor compared with a distal monitor.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGastroesophageal Reflux Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2006
First PostedSep 2006
Primary CompletionMar 2009
Study CompletionJul 2009
TodayJul 2026
First PostedSep 21, 2006
Enrollment StartSep 1, 2006
Primary CompletionMar 1, 2009
Study CompletionJul 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 19.8 years ago
Interventions
BRAVO capsuledevice
Fluoroscopyprocedure
one time "xray" to determine evacuation of bravo
sham BRAVO capsule placementother